152 results
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
of the Company’s named executive officers (a “Say-on-Pay” vote). For 4. To approve the amendment and restatement of the Company’s 2014 Equity Incentive Award
S-8
EX-23.2
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
(Form S-8) pertaining to the Coherus BioSciences, Inc. 2014 Equity Incentive Award Plan of Coherus BioSciences, Inc. of our reports dated March 15, 2024
S-8
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Coherus BioSciences, Inc. 2014 Equity Incentive … Incentive Award Plan (the “Plan”) for which Registration Statements of the Registrant on Form S-8 (File Nos. 333-200593, 333-203356, 333-209936, 333-216679
S-8
EX-5.1
8q7coo3myz12i7x7ud
28 Mar 24
Registration of securities for employees
4:04pm
S-8
ukb86sk58hhpfoylsfdc
28 Mar 24
Registration of securities for employees
4:04pm
8-K
o015h30dfwhh2a fo5t5
22 Feb 24
Departure of Directors or Certain Officers
4:59pm
8-K
EX-2.1
lntjdmcw4cyb82eryoo
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K/A
EX-99.2
l41ix
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-99.1
rdy55rsxvc9 qovfw0eb
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
5nhdt8 v8r0
12 Sep 23
Prospectus supplement for primary offering
6:04am
8-K
iwulkso19n0ls
8 Sep 23
Coherus Completes Surface Oncology Acquisition
9:12am
424B3
ptcbkgt0zp084qz
26 Jul 23
Prospectus supplement
4:59pm